by fiods-ifbdo | Gen 28, 2019 | News |
The IFBDO President, Gian Franco Massaro, and the general Director of the National Blood Centre, Giancarlo Liumbruno’s recent visit to Vietnam has built a “bridge” between Italian and Asian blood donors. During their 4 days trip, the Italian delegation has laid the foundations for a possible cooperation between the two Countries, besides rewarding the Vietnamese donors’ experiences. The mission coincided with the celebration of the 25th anniversary of the Hanoi young donors Foundation. During the event, IFBDO international crosses of merit have been awarded to Bach Quoc Khanh, Director of the National Institute of Hematology, and to Nguyen Thi Xuan Thu, President of the Red Cross. During several meetings among the Italian delegation and the local blood world representatives, from the Director of the Vietnamese equivalent of the National Blood Centre, to the Hanoi young donors association and the local Red Cross, all the different aspects of donation and blood and hemoderivatives safety have been discussed. Vietnam has a blood collection system very similar to the Italian one, with almost 1.250.000 units collected, 97.4% of which being voluntarily collected and without remuneration, while the rest coming from “family” donation and paid donation. The Country has almost 95 million inhabitants, spread over an area slightly bigger than...
by fiods-ifbdo | Gen 27, 2019 | News |
The Platform of Plasma Protein Users organised a Consensus Conference in Estoril, Portugal on 24-25 January 2019 bringing together different stakeholder organisations active in the field of blood and plasma collection and fractionation. The following key principles were identified and endorsed by the stakeholders listed below during the meeting. This, with a view to inform future policy discussions in Europe around the collection of blood and plasma. These principles will also be helpful in the context of a potential revision of the EU Blood Directive. Recognition that Plasma Derived Medicinal Products (PDMPs) are life-saving therapies. Patient organisations representing the communities dependent on a stable supply of PDMPs should be involved in policy decision-making. Patient organisations call for global sufficiency of PDMPs as the ultimate goal of any regional effort to collect more plasma. Any measure or new policy aimed at increasing blood and plasma collection should ensure that it is both patient- and donor-centered, with the goal to meet growing clinical needs. Education on health questions regarding blood and plasma should be promoted throughout Europe. All measures and policies should respect and promote health and safety for patients. All measures and policies should respect and promote quality, safety of blood and plasma collection, including donors’ safety. In the interest of transparency, blood and plasma donors should be informed about how their donation can be used. Measures to increase blood collection may be different from the ones aimed at increasing plasma collection. Plasma collection through plasmapheresis is key to ensure Europe can increase its supply of plasma for fractionation. Avoiding wastage of recovered plasma is also important. All...
